Fintech PR
Basware Appoints Head of AI and CIO to Lead Innovation Drive
Two experts will further Basware’s investment and leadership position with its AI product offering and digital transformation
CHARLOTTE, N.C. and HELSINKI, Finland, Feb. 28, 2024 /PRNewswire/ — Basware, a global leader in AP automation and invoice processing, has announced the appointments of Anssi Ruokonen as its Director of AI Research and Enablement, and Barrett Schiwitz as its new Chief Information Officer (CIO).
Ruokonen will further enhance AI technology within Basware’s product and service offering, while Schiwitz will oversee Basware’s digital transformation projects to deliver an ever-improving customer experience.
Generative AI has the potential to generate upwards of $4.4 trillion across all industries, according to McKinsey. Basware’s AI strategy is centered around expanding its innovation lead within its product offering and doing better with its customer experience.
The company is already utilizing AI through its SmartPDF system which automates the conversion of machine-readable PDFs to e-invoices with over 97 per cent accuracy, removing the need for outdated manual processes. Last year, Basware also teamed up with Microsoft to announce the use of ChatGPT within its customer support function, called AskMary.
Ruokonen will lead Basware’s AI development, shaping the company’s strategy, research and approach to AI, implementing AI technology to optimize Basware’s product offering and enhance operations across the business. He joins from AI firm Fluentic where he served as Chief Product Officer.
Ruokonen will be based in Helsinki, Finland and be part of Basware’s Products, Cloud Engineering & Operations (PCE&O) function.
Anssi Ruokonen, Director of AI Research and Enablement, Basware, said: “Basware’s commitment to leveraging AI in transforming business operations is exciting and I’m fascinated by AI’s potential in revolutionizing industries. Basware’s position enables us to leverage AI in every aspect of our business, directly translating to increased customer value. By automating routine tasks, AI frees up human intellect to focus on creativity and strategic thinking. The democratization of AI means not just easing existing work, but empowering every team member with new capabilities.”
Basware is a world-leader in AP automation, developing and integrating AI solutions to deliver benefits across the invoice processing cycle, including invoice capture, data extraction and PO (purchase order) matching. Through SmartCoding, Basware further automates the coding of invoices without a PO. SmartCoding leverages AI and uses the history of a supplier’s invoices to automatically code and send invoices along the workflow by creating rules for non-PO invoices. Basware Insights has further harnessed AI to identify the risk of late invoice payments, capture early payment discounts, and analyze patterns in transaction data to help predict cash flow.
Meanwhile, as Chief Information Officer (CIO), Barrett Schiwitz will oversee Basware’s digital transformation projects including the technological advancement and management of Basware’s internal digital transformation to allow staff to better serve customers. The project will completely revamp Basware’s systems and data across all functions, starting with customer facing areas. This initiative will be supported by major investments in new systems and education to empower staff to deliver more value to customers.
With more than 30 years’ experience in the technology sector as a transformation leader, implementer and software developer, Schiwitz will strengthen Basware’s technology team as part of the company’s overall digital strategy. Prior to Basware, Schiwitz served as SVP of Integration and Business Transformation at tech firm Snap One.
Based in Atlanta, Georgia, Schiwitz will be a part of the executive team and report into CEO Jason Kurtz.
Barrett Schiwitz, Chief Information Officer, Basware, said: “Technology plays a central role in any successful business, from finance functions to sales and marketing, and Basware’s emphasis on innovation with products and services that make a difference stood out from the rest. I’m excited to be a part of the team and leverage my experience to make an impact by leading the digital transformation strategy across the business to make technology work better for employees and customers.”
About Basware
Basware is how finance leaders in global enterprises can finally automate their complex, labor-intensive invoice processes and stay compliant with regulatory change. Our AP automation and invoicing platform helps you achieve a new level of efficiency – in a matter of months – while reducing errors and risks. We bring a unique combination of true automation, complete coverage, and deeper expertise to make it all just happen for our customers. That’s why the world’s most efficient AP departments at thousands of companies rely on Basware to handle over 220 million invoices per year. Basware. Now it all just happens.™
Photo – https://mma.prnewswire.com/media/2347331/Barrett_Schiwitz_And_Anssi_Ruokonen.jpg
View original content:https://www.prnewswire.co.uk/news-releases/basware-appoints-head-of-ai-and-cio-to-lead-innovation-drive-302071195.html
STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.
The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.
To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.
The webcast can be followed live here and a recording will be available afterwards.
Information on EQT AB’s financial reporting
The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.
The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.
Contact
Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]
Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/eqt/r/invitation-to-presentation-of-eqt-ab-s-q1-announcement-2024,c3956826
The following files are available for download:
|
Invitation to presentation of EQT AB’s Q1 Announcement 2024 |
|
|
EQT AB Group |
View original content:https://www.prnewswire.co.uk/news-releases/invitation-to-presentation-of-eqt-abs-q1-announcement-2024-302109147.html
- Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
- Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
- Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
- Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
- PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
- Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
- 2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
- CEO reaffirms Kia’s commitment to ESG management
SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.
Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.
During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.
The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.
“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”
Photo – https://mma.prnewswire.com/media/2380039/Photo_1__2024_CEO_Investor_Day.jpg
PDF – https://mma.prnewswire.com/media/2380040/Press_Release__2024_Kia_CEO_Investor_Day_240405.pdf
View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/kia-presents-roadmap-to-lead-global-electrification-era-through-evs-hevs-and-pbvs-302109142.html
VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.
As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.
The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.
Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.
About BioVaxys Technology Corp.
BioVaxys Technology Corp. (www.biovaxys.com), a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit www.biovaxys.com and connect with us on X and LinkedIn.
ON BEHALF OF THE BOARD
Signed “James Passin“
James Passin, Chief Executive Officer
Phone: +1 646 452 7054
Logo – https://mma.prnewswire.com/media/1430981/BIOVAXYS_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/biovaxys-technology-corp-provides-bi-weekly-mcto-status-update-302108920.html
-
Latest News6 days ago
TerraPay Continues to Attract Top Industry Talent, Names Hassan Chatila as Vice President and Global Head of Network
-
Latest News6 days ago
The General Assembly of Siniora Food Industries Company approved the distribution of cash dividends amounting to JD 4.2 million representing 15% of its paid-in capital, and stock dividends amounting to 2,147,059 shares
-
Latest News6 days ago
IRIS Business Services Introduces “IRIS Myeinvois” SaaS Platform for Seamless e-Invoice Compliance in Malaysia
-
Latest News6 days ago
Top 10 Sessions You Can’t Miss at MARE BALTICUM Gaming & TECH Summit 2024 (Tallinn, Estonia, 4-5 June)
-
Latest News6 days ago
Halal Economy Leadership Forum 2024 Riyadh: IsDB, HPDC and HDC’s Collaboration to Spearhead Innovation for Global Halal Industry
-
Latest News4 days ago
Mashreq Partners with Silent Eight for Compliance Alert Adjudication
-
Latest News6 days ago
ICEYE Announces API That Allows Customers to Directly Task World’s Largest SAR Satellite Constellation
-
Latest News5 days ago
Wego and Moroccan National Tourist Office Forge Strategic Alliance, Unveiled at the Arabian Travel Market (ATM)